United States · FDA National Drug Code directory
Azelastine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-477_b5281403-77e2-44a3-966f-d9c9efb86453
- Product NDC
- 67877-477
- Form
- SPRAY, METERED
- Composition / generic term
- Azelastine
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170818
- Source listing expiry
- 20271231
Source-listed ingredients
- AZELASTINE HYDROCHLORIDE — 137 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SPRAY, METERED in 1 BOTTLE (67877-477-50) · 67877-477-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →